|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O’Day E and Lal A: MicroRNAs and their
target gene networks in breast cancer. Breast Cancer Res.
12:2012010. View
Article : Google Scholar
|
|
4
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brennecke J and Cohen SM: Towards a
complete description of the microRNA complement of animal genomes.
Genome Biol. 4:2282003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Plummer PN, Freeman R, Taft RJ, Vider J,
Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al:
MicroRNAs regulate tumor angiogenesis modulated by endothelial
progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar
|
|
7
|
Li Q, Zhu F and Chen P: miR-7 and miR-218
epigenetically control tumor suppressor genes RASSF1A and Claudin-6
by targeting HoxB3 in breast cancer. Biochem Biophys Res Commun.
424:28–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Markou A, Yousef GM, Stathopoulos E,
Georgoulias V and Lianidou E: Prognostic significance of
metastasis-related microRNAs in early breast cancer patients with a
long follow-up. Clin Chem. 60:197–205. 2014. View Article : Google Scholar
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meister G, Landthaler M, Dorsett Y and
Tuschl T: Sequence-specific inhibition of microRNA- and
siRNA-induced RNA silencing. RNA. 10:544–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sachdeva M and Mo YY: MicroRNA-145
suppresses cell invasion and metastasis by directly targeting mucin
1. Cancer Res. 70:378–387. 2010. View Article : Google Scholar :
|
|
15
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y,
Du X and Han W: microRNA-365, down-regulated in colon cancer,
inhibits cell cycle progression and promotes apoptosis of colon
cancer cells by probably targeting Cyclin D1 and Bcl-2.
Carcinogenesis. 33:220–225. 2012. View Article : Google Scholar
|
|
17
|
Zhou M, Liu W, Ma S, Cao H, Peng X, Guo L,
Zhou X, Zheng L, Guo L, Wan M, et al: A novel onco-miR-365 induces
cutaneous squamous cell carcinoma. Carcinogenesis. 34:1653–1659.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shah NR and Chen H: MicroRNAs in
pathogenesis of breast cancer: Implications in diagnosis and
treatment. World J Clin Oncol. 5:48–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blondal T, Jensby Nielsen S, Baker A,
Andreasen D, Mouritzen P, Wrang Teilum M and Dahlsveen IK:
Assessing sample and miRNA profile quality in serum and plasma or
other biofluids. Methods. 59:S1–S6. 2013. View Article : Google Scholar
|
|
21
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37:Database. D98–D104. 2009. View Article : Google Scholar :
|
|
22
|
Li P, Xie XB, Chen Q, Pang GL, Luo W, Tu
JC, Zheng F, Liu SM, Han L, Zhang JK, et al: MiRNA-15a mediates
cell cycle arrest and potentiates apoptosis in breast cancer cells
by targeting synuclein-γ. Asian Pac J Cancer Prev. 15:6949–6954.
2014. View Article : Google Scholar
|
|
23
|
Dobson JR, Taipaleenmäki H, Hu YJ, Hong D,
van Wijnen AJ, Stein JL, Stein GS, Lian JB and Pratap J:
hsa-miR-30c promotes the invasive phenotype of metastatic breast
cancer cells by targeting NOV/CCN3. Cancer Cell Int. 14:732014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmad A, Sethi S, Chen W, Ali-Fehmi R,
Mittal S and Sarkar FH: Up-regulation of microRNA-10b is associated
with the development of breast cancer brain metastasis. Am J Transl
Res. 6:384–390. 2014.PubMed/NCBI
|
|
25
|
Shen J, Hu Q, Schrauder M, Yan L, Wang D,
Medico L, Guo Y, Yao S, Zhu Q, Liu B, et al: Circulating miR-148b
and miR-133a as biomarkers for breast cancer detection. Oncotarget.
5:5284–5294. 2014.PubMed/NCBI
|
|
26
|
Ma T, Zhang J, Wu J and Tang J: Effect of
miR-342-3p on chemotherapy sensitivity in triple-negative breast
cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 39:488–495. 2014.(In
Chinese). PubMed/NCBI
|
|
27
|
Llamazares M, Obaya AJ, Moncada-Pazos A,
Heljasvaara R, Espada J, López-Otín C and Cal S: The ADAMTS12
metalloproteinase exhibits anti-tumorigenic properties through
modulation of the Ras-dependent ERK signalling pathway. J Cell Sci.
120:3544–3552. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Porter S, Scott SD, Sassoon EM, Williams
MR, Jones JL, Girling AC, Ball RY and Edwards DR: Dysregulated
expression of adamalysin-thrombospondin genes in human breast
carcinoma. Clin Cancer Res. 10:2429–2440. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Porter S, Span PN, Sweep FC, Tjan-Heijnen
VC, Pennington CJ, Pedersen TX, Johnsen M, Lund LR, Rømer J and
Edwards DR: ADAMTS8 and ADAMTS15 expression predicts survival in
human breast carcinoma. Int J Cancer. 118:1241–1247. 2006.
View Article : Google Scholar
|
|
30
|
Rocks N, Paulissen G, Quesada Calvo F,
Polette M, Gueders M, Munaut C, Foidart JM, Noel A, Birembaut P and
Cataldo D: Expression of a disintegrin and metalloprotease (ADAM
and ADAMTS) enzymes in human non-small-cell lung carcinomas
(NSCLC). Br J Cancer. 94:724–730. 2006.PubMed/NCBI
|
|
31
|
Kuno K, Terashima Y and Matsushima K:
ADAMTS-1 is an active metalloproteinase associated with the
extracellular matrix. J Biol Chem. 274:18821–18826. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rocks N, Paulissen G, Quesada-Calvo F,
Munaut C, Gonzalez ML, Gueders M, Hacha J, Gilles C, Foidart JM,
Noel A, et al: ADAMTS-1 metalloproteinase promotes tumor
development through the induction of a stromal reaction in vivo.
Cancer Res. 68:9541–9550. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Masui T, Hosotani R, Tsuji S, Miyamoto Y,
Yasuda S, Ida J, Nakajima S, Kawaguchi M, Kobayashi H, Koizumi M,
et al: Expression of METH-1 and METH-2 in pancreatic cancer. Clin
Cancer Res. 7:3437–3443. 2001.PubMed/NCBI
|
|
34
|
Freitas VM, do Amaral JB, Silva TA, Santos
ES, Mangone FR, Pinheiro JJ, Jaeger RG, Nagai MA and
Machado-Santelli GM: Decreased expression of ADAMTS-1 in human
breast tumors stimulates migration and invasion. Mol Cancer.
12:22013. View Article : Google Scholar : PubMed/NCBI
|
